Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hironari Hanaoka

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 22, 2013
[Anti-cytokine treatment, newly developed]Hironari Hanaoka, Tsutomu Takeuchi
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|September 3, 2013
Interferon α-targeted therapyHironari Hanaoka, Tsutomu Takeuchi
International Journal of Rheumatic Diseases|July 17, 2015
Glomerulomegaly in lupus nephritis: a prognostic marker for renal outcomesHironari Hanaoka, Masataka Kuwana, Tsutomu Takeuchi
Clinical Rheumatology|January 9, 2016
Poor renal outcomes in patients with anti-neutrophil cytoplasmic antibody-associated crescentic glomerulonephritis and normal renal function at diagnosisHironari Hanaoka, Yuichiro Ota, Tsutomu Takeuchi, et al.
Modern Rheumatology|January 8, 2015
Early achievement of complete renal response predicts good long-term renal outcome and low systemic damage in newly diagnosed lupus nephritis class III or IVHironari Hanaoka, Yuko Kaneko, Masataka Kuwana, et al.
International Journal of Rheumatic Diseases|November 9, 2018
Low additive effect of hydroxychloroquine on Japanese patients with systemic lupus erythematosus taking calcineurin inhibitorHironari Hanaoka, Harunobu Iida, Tomofumi Kiyokawa, et al.
Internal Medicine (Tokyo, Japan)|January 11, 2019
Hydroxychloroquine Improves the Disease Activity and Allows the Reduction of the Corticosteroid Dose Regardless of Background Treatment in Japanese Patients with Systemic Lupus ErythematosusHironari Hanaoka, Harunobu Iida, Tomofumi Kiyokawa, et al.
Internal Medicine (Tokyo, Japan)|June 26, 2020
An Overlapping Case of IgG4-related Disease and Klinefelter Syndrome with Lupus-like Serological and Neurological Features: A Case Report and Literature ReviewSatoshi Takanashi, Hironari Hanaoka, Yuichiro Ota, et al.
Internal Medicine (Tokyo, Japan)|May 8, 2015
Acute kidney injury due to renal sarcoidosis during etanercept therapy: a case report and literature reviewMitsuhiro Akiyama, Yuko Kaneko, Hironari Hanaoka, et al.
Modern Rheumatology|June 3, 2014
Polychondritis presenting with oculomotor and abducens nerve palsies as the initial manifestationMitsuhiro Akiyama, Yuko Kaneko, Hironari Hanaoka, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 22, 2013
[Anti-cytokine treatment, newly developed]Hironari Hanaoka, Tsutomu Takeuchi
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|September 3, 2013
Interferon α-targeted therapyHironari Hanaoka, Tsutomu Takeuchi
International Journal of Rheumatic Diseases|July 17, 2015
Glomerulomegaly in lupus nephritis: a prognostic marker for renal outcomesHironari Hanaoka, Masataka Kuwana, Tsutomu Takeuchi
Clinical Rheumatology|January 9, 2016
Poor renal outcomes in patients with anti-neutrophil cytoplasmic antibody-associated crescentic glomerulonephritis and normal renal function at diagnosisHironari Hanaoka, Yuichiro Ota, Tsutomu Takeuchi, et al.
Modern Rheumatology|January 8, 2015
Early achievement of complete renal response predicts good long-term renal outcome and low systemic damage in newly diagnosed lupus nephritis class III or IVHironari Hanaoka, Yuko Kaneko, Masataka Kuwana, et al.
International Journal of Rheumatic Diseases|November 9, 2018
Low additive effect of hydroxychloroquine on Japanese patients with systemic lupus erythematosus taking calcineurin inhibitorHironari Hanaoka, Harunobu Iida, Tomofumi Kiyokawa, et al.
Internal Medicine (Tokyo, Japan)|January 11, 2019
Hydroxychloroquine Improves the Disease Activity and Allows the Reduction of the Corticosteroid Dose Regardless of Background Treatment in Japanese Patients with Systemic Lupus ErythematosusHironari Hanaoka, Harunobu Iida, Tomofumi Kiyokawa, et al.
Internal Medicine (Tokyo, Japan)|June 26, 2020
An Overlapping Case of IgG4-related Disease and Klinefelter Syndrome with Lupus-like Serological and Neurological Features: A Case Report and Literature ReviewSatoshi Takanashi, Hironari Hanaoka, Yuichiro Ota, et al.
Internal Medicine (Tokyo, Japan)|May 8, 2015
Acute kidney injury due to renal sarcoidosis during etanercept therapy: a case report and literature reviewMitsuhiro Akiyama, Yuko Kaneko, Hironari Hanaoka, et al.
Modern Rheumatology|June 3, 2014
Polychondritis presenting with oculomotor and abducens nerve palsies as the initial manifestationMitsuhiro Akiyama, Yuko Kaneko, Hironari Hanaoka, et al.
Pageof 7